DocGo (DCGO) EBIT (2020 - 2026)

DocGo's EBIT history runs 7 years deep, the most recent figure standing at -$18.7 million for Q1 2026.

• In Q1 2026, EBIT fell 33.68% year-over-year to -$18.7 million; the TTM figure through Mar 2026 stood at -$182.7 million (down 15333.7% YoY), while the FY2025 annual figure was -$178.0 million, down 720.57% from the prior year.
• EBIT for Q1 2026 stood at -$18.7 million, up from -$104.6 million in the prior quarter.
• The five-year high for EBIT was $15.9 million in Q1 2024, with the low at -$104.6 million in Q4 2025.
• The 5-year median for EBIT is $1.6 million (2023), against an average of -$7.7 million.
• The sharpest annual moves came in 2023 and 2025: EBIT soared 14470.94% in 2023, then sank 1299.4% in 2025.
• DocGo's EBIT stood at $80116.0 in 2022, then jumped by 14470.94% to $11.7 million in 2023, then slumped by 164.02% to -$7.5 million in 2024, then tumbled by 1299.4% to -$104.6 million in 2025, then jumped by 82.11% to -$18.7 million in 2026.
• Business Quant data shows DCGO's EBIT at -$18.7 million in Q1 2026, -$104.6 million in Q4 2025, and -$42.0 million in Q3 2025.